Evidence map›Paper›PMID 28117570›Full record

ArticleACS applied materials & interfaces2017

Nanoparticle-Programmed Surface for Drug Release and Cell Regulation via Reversible Hybridization Reaction.

Pinliang Jiang, Shihui Li, Jinping Lai, Hong Zheng, Changjian Lin, Peng Shi, Yong Wang

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Programmable hydrogels.Biomaterials · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pinliang JiangDepartment of Biomedical Engineering, The Pennsylvania State University , University Park, Pennsylvania 16802, United States.
Shihui LiDepartment of Biomedical Engineering, The Pennsylvania State University , University Park, Pennsylvania 16802, United States.
Jinping LaiDepartment of Biomedical Engineering, The Pennsylvania State University , University Park, Pennsylvania 16802, United States.
Hong ZhengDepartment of Biomedical Engineering, The Pennsylvania State University , University Park, Pennsylvania 16802, United States.
Changjian LinDepartment of Chemistry, College of Chemistry and Chemical Engineering & College of Materials, Xiamen University , Xiamen 361005, China.
Peng ShiDepartment of Biomedical Engineering, The Pennsylvania State University , University Park, Pennsylvania 16802, United States.
Yong WangDepartment of Biomedical Engineering, The Pennsylvania State University , University Park, Pennsylvania 16802, United States.ORCID http://orcid.org/0000-0002-2244-1742

Funding

Molecularly regulated release of angiogenic factors from superporous hydrogelsR01HL122311 · NHLBI · PENNSYLVANIA STATE UNIVERSITY, THE · PI WANG, YONG · 2015 to 2023
$4.2M
NHLBI NIH HHS R01 HL122311
6 · The paper itself

Abstract

A surface directly connects the bulk of a material to its surroundings. The ability to dynamically regulate the surface without affecting the bulk of a material holds great potential for new applications. The purpose of this work was to demonstrate that the surface can be dynamically changed using nanoparticles and oligonucleotides (ODNs) in a reversible and reiterative manner. A dual-functional nanogel was synthesized as the model of nanoparticles using miniemulsion polymerization and click chemistry. The nanogel can not only adsorb drugs for sustained drug release but also bind a surface functionalized with complementary ODNs. Importantly, hybridization reaction and ODN degradation can drive reversible and reiterative nanogel binding to the surface for dynamic change, which in principle is unlimited. Moreover, nanogel-mediated dynamic change offers the surface with the drug-releasing function for inhibiting the growth of surrounding cells. Because nanogels can be replaced by any functional nanoparticles with a diverse array of properties, nanoparticle-programmed surface change constitutes a promising platform for various applications such as drug delivery and stent implantation.

Indexed as

NanoparticlesDrug CarriersDrug Delivery SystemsDrug LiberationPolyethylene GlycolsPolyethyleneimineDrug CarriersPolyethylene GlycolsPolyethyleneiminecell regulationDNAshydrogelsnanoparticlessurfaces

Identifiers

PMID28117570
PMCPMC5462454

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.